Mizuho Asset Management’s Edwards Lifesciences EW Stock Holding History

Mizuho Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$229K	Sell	5,709 -2,859	-33%	-$108K	0.05%	257
2016 Q2	$285K	Buy	8,568 +6,333	+283%	+$217K	0.05%	282
2016 Q1	$106K	Sell	2,235 -5,877	-72%	-$162K	0.03%	338
2015 Q4	$214K	Buy	8,112 +1,080	+15%	+$28K	0.04%	305
2015 Q3	$167K	Buy	7,032 +1,188	+20%	+$28.7K	0.04%	318
2015 Q2	$139K	Buy	5,844 +1,374	+31%	+$31K	0.03%	334
2015 Q1	$106K	Buy	4,470 +2,088	+88%	+$46.8K	0.03%	338
2014 Q4	$51K	Hold	2,382	–	–	0.02%	430
2014 Q3	$41K	Buy	2,382 +1,302	+121%	+$20.6K	0.01%	410
2014 Q2	$15K	Hold	1,080	–	–	﹤0.01%	626
2014 Q1	$13K	Hold	1,080	–	–	﹤0.01%	589
2013 Q4	$12K	Hold	1,080	–	–	﹤0.01%	571
2013 Q3	$13K	Hold	1,080	–	–	﹤0.01%	571
2013 Q2	$12K	Buy	+1,080	New	+$12.8K	﹤0.01%	558

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mizuho Asset Management's EW Position: Q3 2016 in Review

Mizuho Asset Management reduced its Edwards Lifesciences (EW) stake by 33% in Q3 2016, selling an estimated $108K and leaving 5,709 shares worth $229K. The position accounts for 0.05% of the portfolio, ranked #257.

Mizuho Asset Management first reported a position in EW in Q2 2013 and has held it in 14 quarters since. The position peaked at $285K in Q2 2016. 694 funds tracked by Wall St. Rank hold EW as of Q3 2016.

Mizuho Asset Management held 5,709 shares of Edwards Lifesciences worth $229K as of Q3 2016.
Mizuho Asset Management sold 2,859 Edwards Lifesciences shares in Q3 2016, an estimated $108K.
Edwards Lifesciences made up 0.05% of Mizuho Asset Management's portfolio in Q3 2016, its #257 holding.
Mizuho Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 14 quarters since.
Mizuho Asset Management's Edwards Lifesciences position peaked at $285K in Q2 2016.
694 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.